Table 4

Patients Who Engaged in Activities That Could Have Modified Symptoms of Depression or Suicide Ideation or Behavior at Follow-up, by General Practitioner Study Group

ResultsControl n (%)Intervention n (%)Crude OR (95% CI)Adjusted ORa (95% CI)
All patients
Total, n10,36011,402
Antidepressant use1,400 (13.5)1,442 (12.6)0.93 (0.86–1.00)0.95 (0.87–1.03)
Contact with mental health professionals738 (7.1)817 (7.2)1.00 (0.90–1.11)1.02 (0.91–1.13)
Other nonspecified support912 (8.8)1,055 (9.3)1.04 (0.95–1.14)1.07 (0.97–1.18)
Physician completed a minimum of 10 audits8,106 (78.2)9,440 (82.8)1.34 (1.25–1.43)b
Patients free of clinically significant symptoms of depression and suicide ideation at baseline assessment who remained free of symptoms during follow-up
Total, n7,3758,281
Antidepressant use760 (10.3)844 (10.2)0.98 (0.88–1.09)1.02 (0.92–1.14)
Contact with mental health professionals430 (5.8)510 (6.2)1.09 (0.95–1.26)1.08 (0.94–1.25)
Other nonspecified support617 (8.4)735 (8.9)1.08 (0.96–1.22)1.10 (0.97–1.24)
Physician completed a minimum of 10 audits6,067 (82.3)7,171 (86.6)1.33 (1.23–1.44)b
Patients who displayed clinically significant symptoms of depression, suicide ideation, or both at baseline but neither during follow-up
Total, n440501
Antidepressant use63 (14.3)53 (10.6)0.71 (0.48–1.05)0.72 (0.48–1.07)
Contact with mental health professionals31 (7.0)26 (5.2)0.75 (0.43–1.28)0.75 (0.43–1.31)
Other nonspecified support45 (10.2)37 (7.4)0.71 (0.45–1.13)0.71 (0.44–1.13)
Physician completed a minimum of 10 audits352 (80.0)410 (81.8)1.13 (0.81–1.56)
  • Note: Percentages displayed use the total number of participants in the relevant groups as the denominator, including missing cases. Information on the composite at baseline was missing for 397 and 415 older adults in the control and intervention groups, respectively. The table also displays data on compliance with minimum audit requirements of control and intervention physicians.

  • a Adjusted for age, sex, migrant and marital status, living arrangements, education, and number of comorbidities.

  • b P <.05.